CSF2 has been demonstrated to have a protective impact on atherogenesis (6), and the administration of CSF2 has been reported to prevent the progression of atherosclerosis via changes in the composition of atherosclerotic lesions (7). This evidence concerns the gene CSF2 and atherosclerosis.